FDA Inspection
Georgia Eye Bank, Inc.Georgia Eye Bank, Inc. – FDA Inspection, May 24, 2019
Record Details
This FDA Inspection record concerns Georgia Eye Bank, Inc., with an inspection on May 24, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ad7a4b7b-d888-4124-b02f-3ff42160ddee
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1090641
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.230(a)Process validation procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Georgia Eye Bank, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 30, 2026 | Not classified | Atlanta District Office | Human Cellular, Tissue, and Gene Therapies |
| November 8, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 28, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 19, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 1, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Georgia Eye Bank, Inc.
- FDA Inspection 1314808 - 2026-04-30
- FDA Inspection 1192021 - 2022-11-08
- FDA Inspection 1028414 - 2017-09-28
- FDA Inspection 938757 - 2015-08-19
- FDA Inspection 829797 - 2013-05-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.